{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:18:23Z","timestamp":1789017503046,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jceh.2017.01.115","type":"journal-article","created":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T03:01:41Z","timestamp":1486350101000},"page":"55-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Role of Allopurinol in Optimizing Thiopurine Therapy in Patients with Autoimmune Hepatitis: A Review"],"prefix":"10.1016","volume":"7","author":[{"given":"Shivani","family":"Deswal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshu","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2017.01.115_bib0210","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL practice guidelines: autoimmune liver disease","volume":"63","author":"European Association for Study of Liver","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2017.01.115_bib0215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.14218\/JCTH.2014.00032","article-title":"Update on autoimmune hepatitis","volume":"3","author":"Liberal","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jceh.2017.01.115_bib0220","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.cgh.2015.08.012","article-title":"Autoimmune hepatitis and overlap syndromes: diagnosis and Management","volume":"13","author":"Vierling","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2017.01.115_bib0225","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2017.01.115_bib0230","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jceh.2017.01.115_bib0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jceh.2017.01.115_bib0240","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"American Association for the Study of Liver Disease. Diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jceh.2017.01.115_bib0245","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2010.01.037","article-title":"Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials","volume":"53","author":"Lamers","year":"2010","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jceh.2017.01.115_bib0250","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.jceh.2017.01.115_bib0255","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1155\/2013\/981086","article-title":"Challenges in the diagnosis and management of autoimmune hepatitis","volume":"27","author":"Czaja","year":"2013","journal-title":"Can J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jceh.2017.01.115_bib0260","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1440-1746.2009.06018.x","article-title":"Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes","volume":"25","author":"Yokokawa","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2017.01.115_bib0265","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/FTD.0b013e3181dbd712","article-title":"Monitoring of azathioprine metabolites in pediatric patients with autoimmune liver disease","volume":"32","author":"Nguyen","year":"2010","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jceh.2017.01.115_bib0270","first-page":"391","article-title":"Azathioprine metabolite measurements in the treatment of autoimmune liver disease in pediatric patients: a preliminary report","volume":"35","author":"Rumbo","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jceh.2017.01.115_bib0275","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1440-1746.2005.03832.x","article-title":"Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease","volume":"20","author":"Gearry","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2017.01.115_bib0280","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.3748\/wjg.v20.i13.3475","article-title":"Therapeutic drug monitoring in patients with inflammatory bowel disease","volume":"20","author":"Yarur","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jceh.2017.01.115_bib0285","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/hep.25760","article-title":"Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis","volume":"56","author":"Dhaliwal","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jceh.2017.01.115_bib0290","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.jceh.2017.01.115_bib0295","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2036.2005.02636.x","article-title":"Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease","volume":"22","author":"Bastida","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2017.01.115_bib0300","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1111\/j.1572-0241.2007.01515.x","article-title":"Hepatotoxicity of 6-mercaptopurine (6-MP) and azathioprine (AZA) in adult IBD patients","volume":"102","author":"Shaye","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2017.01.115_bib0305","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/apt.12223","article-title":"Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune liver disease","volume":"37","author":"de Boer","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2017.01.115_bib0310","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MIB.0000000000000197","article-title":"Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD","volume":"21","author":"Amin","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jceh.2017.01.115_bib0315","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/2040622315579063","article-title":"Optimizing the use of thiopurines in inflammatory bowel disease","volume":"6","author":"Goel","year":"2015","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.jceh.2017.01.115_bib0320","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1445-5994.2012.02936.x","article-title":"Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease","volume":"43","author":"Kennedy","year":"2013","journal-title":"Intern Med J"},{"key":"10.1016\/j.jceh.2017.01.115_bib0325","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1365-2036.2005.02703.x","article-title":"Observation in the use of allopurinol in combination with azathioprine or mercaptopurine (letter)","volume":"22","author":"Duley","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jceh.2017.01.115_bib0330","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bcp.2013.06.002","article-title":"Mechanism of allopurinol induced TPMT inhibition","volume":"86","author":"Blaker","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.jceh.2017.01.115_bib0335","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MPG.0b013e3181d29750","article-title":"Allopurinol salvage therapy in pediatric overlap autoimmune hepatitis-primary sclerosing cholangitis with 6-MMP toxicity","volume":"51","author":"Dunkin","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.jceh.2017.01.115_bib0340","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/hep.26198","article-title":"Use of a xanthine oxidase inhibitor in autoimmune hepatitis","volume":"57","author":"Al-Shamma","year":"2013","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jceh.2017.01.115_bib0345","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/FTD.0b013e31815bf4dc","article-title":"The role of xanthine oxidase in thiopurine metabolism: a case report","volume":"29","author":"Wong","year":"2007","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jceh.2017.01.115_bib0350","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/apt.12285","article-title":"Allopurinol co-therapy is safe and effective in autoimmune hepatitis (Letter)","volume":"37","author":"Al-Shamma","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"920","key":"10.1016\/j.jceh.2017.01.115_bib0355","first-page":"918","article-title":"Allopurinol co-therapy is safe and effective in autoimmune hepatitis (Letter \u2013 authors\u2019 reply)","volume":"37","author":"de Boer","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2017.01.115_bib0360","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000116934","article-title":"Reversible peripheral neuropathy","volume":"33","author":"Azulay","year":"1993","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jceh.2017.01.115_bib0365","series-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","article-title":"Chapter 34. Anti-inflammatory, antipyretic and analgesic agents; pharmacotherapy of gout","author":"Grosser","year":"2011"},{"issue":"4","key":"10.1016\/j.jceh.2017.01.115_bib0370","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrrheum.2015.132","article-title":"Allopurinol hypersensitivity: investigating the cause and minimizing the risk","volume":"12","author":"Stamp","year":"2016","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"10.1016\/j.jceh.2017.01.115_bib0375","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jceh.2017.01.115_bib0380","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/ibd.20522","article-title":"Initial clinical experience with allopurinol-thiopurine combination therapy in pediatric IBD","volume":"14","author":"Rahhal","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jceh.2017.01.115_bib0385","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1440-1746.2010.06254.x","article-title":"Azathioprine and allopurinol: a two-edged interaction","volume":"25","author":"Gearry","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2017.01.115_bib0390","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/jcpt.12125","article-title":"Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use","volume":"39","author":"Min","year":"2014","journal-title":"J Clin Pharmacy Ther"},{"issue":"2","key":"10.1016\/j.jceh.2017.01.115_bib0395","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/14656566.7.2.145","article-title":"Cost-effectiveness of pharmacotherapy for autoimmune hepatitis","volume":"7","author":"Heneghan","year":"2006","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"10.1016\/j.jceh.2017.01.115_bib0400","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/FPC.0b013e3282f55e2e","article-title":"Functional characterization of human xanthine oxidase allelic variants","volume":"18","author":"Kudo","year":"2008","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"10.1016\/j.jceh.2017.01.115_bib0405","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00008571-199902000-00006","article-title":"The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations","volume":"9","author":"Collie-Duguid","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jceh.2017.01.115_bib0410","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/BOR.0000000000000031","article-title":"Safety profile of anti-gout agents: an update","volume":"26","author":"Stamp Lisa","year":"2014","journal-title":"Curr Opin Rheumatol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688317301202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688317301202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:04:00Z","timestamp":1760853840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688317301202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0973688317301202"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2017.01.115","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Allopurinol in Optimizing Thiopurine Therapy in Patients with Autoimmune Hepatitis: A Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2017.01.115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 INASL.","name":"copyright","label":"Copyright"}]}}